Company Filing History:
Years Active: 2013-2018
Title: Chad Gwaltney - Innovator in Clinical Endpoint Development
Introduction
Chad Gwaltney is a notable inventor based in Westerly, RI (US), recognized for his contributions to the field of clinical endpoint development. With a focus on utilizing patient-reported outcome data, Gwaltney has developed innovative systems that enhance the reliability of clinical trials.
Latest Patents
Gwaltney holds two significant patents. The first is the "Endpoint Development Process," which outlines a system for developing and producing clinical endpoints based on patient-reported outcome data. This system employs algorithms to generate decision rules for evaluating various health-related quality of life questionnaires, ultimately predicting the reliability of endpoints in supporting medical labeling claims. The second patent, "Clinical Trial Endpoint Development Process," mirrors the first in its objectives and methodologies, further emphasizing the importance of patient-reported outcomes in clinical research.
Career Highlights
Throughout his career, Gwaltney has worked with prominent companies in the healthcare technology sector, including Invivodata, Inc. and eResearchTechnology, Inc. His experience in these organizations has allowed him to refine his expertise in clinical trial methodologies and patient engagement.
Collaborations
Chad has collaborated with esteemed colleagues such as Jean Paty and Alan Shields, contributing to the advancement of clinical endpoint development and enhancing the overall quality of clinical trials.
Conclusion
Chad Gwaltney's innovative work
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.